Research & Development



  多年征戰,大漢帝國依舊頑強的站立著,而大漢帝國的宰相公孫弘卻沒有能熬過這個豐收的秋天。   無鹽詹對劉據有這樣的表現毫不稀奇淡淡的道︰“殿下如果有拿得出來的猛士,盡管一試,只要從台子上把金球搬下來,就能拿走。”大香蕉一本道久在线   如果收繳了弓弩,最不利的不是盜賊,而是捕奴團,也不知道郭解哪來的膽子,竟敢慫恿光祿大夫吾丘壽王上書反對公孫弘禁止民間持有弓弩的做法。大大香蕉一本道国产   劉據見狄山說話艱難,就拉著狄山的手道︰“狄師傅說話不方便,能不說就不說。小光給您造了一本空白書,跟一只炭筆,您以後只需把要說的話寫在空白書上就好。”   劉據忽然笑了,他覺得無鹽詹在蒙騙他。尹人在线大香蕉最快

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo